AIMS Medical Science, 2017, 4(2): 233-240. doi: 10.3934/medsci.2017.2.233.

Research article

Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Lack of Association between Human µ-Opioid Receptor (OPRM1) Gene Polymorphisms and Heroin Addiction in A Sample of Southeast Iranian Population

1 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran;
2 Department of Psychiatry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran;
3 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran;
4 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

It has been proposed that genetic factors account for 30%–50% of the risk for cocaine and heroin addiction. The present study was aimed to find out the impact of µ-opioid receptor gene (OPRM1) rs1799971 A > G and rs9479757 polymorphisms on heroin dependence in a sample of southeast Iranian population. This case-control study was done on 123 heroin addicts and 140 non-addicts Iranian male. Genomic DNA was extracted from peripheral blood cells using salting out method. Genotyping of OPRM1 rs1799971 and rs9479757 polymorphisms were performed using PCR-RFLP method. Overall, our results did not support an association between OPRM1 variants and risk of heroin dependence in a sample of southeast Iranian population. Further studies with larges sample sizes and different ethnicities are required to validate our findings.
  Figure/Table
  Supplementary
  Article Metrics

Keywords OPRM1; polymorphism; addiction; heroin

Citation: Mansour Shakiba, Mohammad Hashemi, Zahra Rahbari, Salah Mahdar, Hiva Danesh, Fatemeh Bizhani, Gholamreza Bahari. Lack of Association between Human µ-Opioid Receptor (OPRM1) Gene Polymorphisms and Heroin Addiction in A Sample of Southeast Iranian Population. AIMS Medical Science, 2017, 4(2): 233-240. doi: 10.3934/medsci.2017.2.233

References

  • 1. Jones JD, Luba RR, Vogelman JL, et al. (2016) Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms. Am J Addict 25: 41-48.    
  • 2. Ridenour TA, Maldonado-Molina M, Compton WM, et al. (2005) Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. Drug Alcohol Depend 80: 1-14.    
  • 3. Kendler KS, Jacobson KC, Prescott CA, et al. (2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160: 687-695.    
  • 4. Tsuang MT, Lyons MJ, Meyer JM, et al. (1998) Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55: 967-972.    
  • 5. van den Bree MB, Johnson EO, Neale MC, et al. (1998) Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend 52: 231-241.    
  • 6. Bond C, LaForge KS, Tian M, et al. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 95: 9608-9613.    
  • 7. Selley DE, Bidlack JM (1992) Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies. J Pharmacol Exp Ther 263: 99-104.
  • 8. Zadina JE, Hackler L, Ge LJ, et al. (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386: 499-502.    
  • 9. Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309-338.    
  • 10. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16: 1-18.    
  • 11. Kreek MJ (1996) Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 21: 1469-1488.    
  • 12. Haerian BS, Haerian MS (2013) OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics 14: 813-824.    
  • 13. Zhang Y, Picetti R, Butelman ER, et al. (2015) Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice. Neuropsychopharmacology 40: 1091-1100.    
  • 14. Franke P, Wang T, Nothen MM, et al. (2001) Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet 105: 114-119.    
  • 15. Xu K, Liu XH, Nagarajan S, et al. (2002) Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet 110: 45-50.    
  • 16. Clarke TK, Crist RC, Kampman KM, et al. (2013) Low frequency genetic variants in the mu-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neurosci Lett 542: 71-75.    
  • 17. Shi J, Hui L, Xu Y, et al. (2002) Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat 19: 459-460.
  • 18. Hashemi M, Hanafi Bojd H, Eskandari Nasab E, et al. (2013) Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease. Hepat Mon 13: e9527.
  • 19. Beer B, Erb R, Pavlic M, et al. (2013) Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One 8: e75359.    
  • 20. Hancock DB, Levy JL, Gaddis NC, et al. (2015) Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biol Psychiatry 78: 474-484.    
  • 21. Wei SG, Zhu YS, Lai JH, et al. (2011) Association between heroin dependence and prodynorphin gene polymorphisms. Brain Res Bull 85: 238-242.    
  • 22. Yuferov V, Ji F, Nielsen DA, et al. (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34: 1185-1197.    
  • 23. Glatt SJ, Bousman C, Wang RS, et al. (2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend 90: 159-165.    
  • 24. Nikolov MA, Beltcheva O, Galabova A, et al. (2011) No evidence of association between 118 A > G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Drug Alcohol Depend 117: 62-65.    
  • 25. Crowley JJ, Oslin DW, Patkar AA, et al. (2003) A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 13: 169-173.    
  • 26. Kumar D, Chakraborty J, Das S (2012) Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuropsychopharmacol Biol Psychiatry 36: 225-230.    
  • 27. Bart G, Kreek MJ, Ott J, et al. (2005) Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30: 417-422.    
  • 28. Woodcock EA, Lundahl LH, Burmeister M, et al. (2015) Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. Am J Addict 24: 329-335.    
  • 29. Nestler EJ (2014) Epigenetic mechanisms of drug addiction. Neuropharmacology 76: 259-268.    
  • 30. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.    
  • 31. Nielsen DA, Utrankar A, Reyes JA, et al. (2012) Epigenetics of drug abuse: predisposition or response. Pharmacogenomics 13: 1149-1160.    
  • 32. Ebrahimi G, Asadikaram G, Akbari H, et al. (2017) Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. Am J Drug Alcohol Abuse 25: 1-7.

 

Reader Comments

your name: *   your email: *  

Copyright Info: © 2017, Mohammad Hashemi, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved